Sundial Growers Inc
NASDAQ:SNDL
Sundial Growers Inc
NASDAQ:SNDL
Price:
2.22 USD
1.83%
Market Closed
Updated:
May 28, 2024
Section:
Relative Value
The Relative Value of one
SNDL
stock under the Base Case scenario is
3.89
USD.
Compared to the current market price of 2.22 USD,
Sundial Growers Inc
is
Undervalued by 43%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
SNDL
Relative Value
Base Case
3.89
USD
Undervaluation 43%
Valuation Multiples
Multiples Across Competitors
SNDL Competitors Multiples
Sundial Growers Inc Competitors
Sundial Growers Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
|
Sundial Growers Inc
NASDAQ:SNDL
|
584.3m USD | 0.9 | -5.7 | 78 | -13.8 | |
| JP |
N
|
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
|
776 550.9T JPY | 4 211 733 | -5 347 888.9 | -5 459 134.4 | -5 046 864.6 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
767.4B USD | 21.4 | 125 | 61.1 | 69.6 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
4.1T DKK | 16.8 | 46 | 34.3 | 37.6 | |
| UK |
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP | 578.3 | -15 783.5 | 3 846.3 | 17 702.3 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
353.7B USD | 4.1 | 9.2 | 11.3 | 14.8 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
328B USD | 5.3 | 142.2 | 35.4 | 57.8 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
188.2B GBP | 5 | 37.9 | 174.6 | 278.6 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
184.3B CHF | 3.1 | 16 | 9.1 | 10.8 | |
| CH |
|
Novartis AG
SIX:NOVN
|
179.5B CHF | 3.3 | 11.2 | 8.5 | 12.5 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
163.7B USD | 3 | -529.7 | 12.8 | 20.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
